Recursion Pharmaceuticals (RXRX) Long-Term Debt Issuances (2020)
Recursion Pharmaceuticals (RXRX) posted Long-Term Debt Issuances of $6.4 million for FY2020, down 46.2% from $11.89 million in FY2019.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Long-Term Debt Issuances (2020) Analysis & Trends
- Business Quant data shows RXRX's Long-Term Debt Issuances at $11.89 million in FY2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.39 Bn | 1,131.97 Bn | 19.71 Bn | 8.94 Bn |
| 2 | Johnson & Johnson | 634.39 Bn | 552.91 Bn | 17.26 Bn | - |
| 3 | AbbVie | 502.68 Bn | 475.79 Bn | 12.70 Bn | - |
| 4 | Merck | 377.37 Bn | 331.74 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 1.98 Bn |
| 6 | Astrazeneca | 266.55 Bn | 240.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 240.56 Bn | 195.96 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.19 Bn | 167.38 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.88 Bn | -721.04 Mn | -3.82 Mn | - |
API Access
Recursion Pharmaceuticals Long-Term Debt Issuances API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-issuances", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();